Alzamend Neuro, Inc. announced plans to start a phase II clinical study of AL001, focusing on its use for patients with bipolar disorder (BD), set to begin in the third quarter of 2025.
6d
News-Medical.Net on MSNNext-generation, inhaled COVID-19 vaccine enters phase-2 clinical trialResearchers at McMaster University have started a phase-2 clinical trial on a next-generation, inhaled COVID-19 vaccine.
Promising multiple dose PK data continue to support 4-weekly dosing FDA advice received supporting phase 2 design in HS ...
Receiving the FDA’s clearance to proceed with our Phase 2 clinical trial for TPST-1495, our second clinical program, in FAP marks an important step forward in developing new treatment options for ...
has completed the enrollment in the Phase 2 clinical study of DR10624 for the treatment of severe hypertriglyceridemia (SHTG) ("DR10624-201 study"). The DR10624-201 study is a randomized ...
We think it can be appropriate to present phase 2 trial participation as offering a small prospect of benefit,” researchers wrote. About 16% of patients enrolled in phase 2 cancer trials receive a ...
BOSTON--(BUSINESS WIRE)--PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology ... decision to temporarily pause the Phase 2 CONNECT2-EDO51 study of PGN-EDO51 in patients with Duchenne ...
Researchers at McMaster University have started a phase-2 clinical trial on a next-generation, inhaled COVID-19 vaccine.
Researchers across 14 medical centers in China, including Peking University People's Hospital, have found that an ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results